An Opportunity to license or acquire novel Powder Encapsulation Technology
for Nonwovens in Healthcare
Request Information
OPPORTUNITY OVERVIEW
A medical market disruptor using Novel Powder Encapsulation Technology to supercharge your nonwoven products
Delivering innovation with measurable economic benefits to transform patient outcomes
Developer of an innovative patent-pending manufacturing process that enables the encapsulation of powders within nonwoven fabrics, unlocking new capabilities across a broad spectrum of applications.
Global Patent Strategy initiated with first filing at the UK Intellectual Property Office in February 2025.
Our scalable process is designed for high-volume, low-cost production of encapsulated and functionalised nonwovens in fabric widths of 5mm-4000mm.
Seeking opportunities to license our IP or explore product IP acquisition, while offering full support across pre-manufacturing development from design, to piloting, to regulatory compliance.
Medical Fabrics Limited is UK based and a self-funded, co-founder owned technology company.
  • No products brought directly to market, we focus on enabling your success, not competing with it.
  • Proprietary manufacturing processes available through tailored commercial arrangements, further protected with product IP.
  • Established partnerships across product design, piloting, testing, regulation and manufacturing for a turn-key solution to bring your products to market.
Clinical Challenges for Medical Devices
Short product life cycles
Medical products often have limited usable lifespans, creating challenges for both patients and healthcare providers.
Convenience of delivering actives
Current methods for delivering active ingredients through medical fabrics can be inefficient or inconsistent.
Increasing device wear time
Patients require medical devices that can be worn comfortably for extended periods without degradation.
Combining functionality with patient comfort
Finding the balance between effective treatment and patient comfort remains a significant challenge.
Digital Health integration
Incorporating digital health features into traditional medical fabrics presents technical hurdles.
Commercial Challenges
1
Commoditisation & Payers
(e.g., NHS, Insurers) driving down prices
Defending reimbursement prices
2
Market Competition
Protecting price premiums from low-cost imitators
Delivering affordable innovation
Cost of European manufacture
Competing with established brands without innovative differentiators
3
Sustainability Concerns
Supply chain environmental impact
Increasing customer focus on sustainability
Innovative Powder Encapsulation Technology
Our technology offers the unique ability to encapsulate functional powders within the fabric of your medical devices creating novel product capabilities. 5mm-4000mm fabric widths / reel-to-reel manufacturing / adhesive-free process
Supercharge your medical device with customisable functions including:
Secure absorbency
Diagnostic indicators
Malodour adsorbing
Imparted electrical field (ES)
Antimicrobial / sterility
Drug deployment
Sustainable & recyclable
Molecular filtration / adsorbency
and much more...
Versatile Material Configurations
Optional cell size, shape, wall width and powder density. Vernier Calipers image shows 1.74mm overall fabric thickness.
Material Combinations
  • Polypropylene, Steel mesh, Sulphur and Epoxy Resin
  • Polypropylene and Fine Activated Carbon
  • Polypropylene, Copper Mesh and Sodium Bicarbonate
  • Polyethylene Terephthalate and Superfine steel mesh with Silicon Dioxide
  • Polythene flat sheet and Sodium Chloride
Variable cell size and shape
Functional Capabilities
Fluid Absorption
✓ Controlled capture of body fluids like sweat, urine or exudate to maintain a required environment.
Malodour Adsorption
✓ Neutralize biological smells by trapping pungent molecules from the surrounding medium.
Pharmaceutical Load
✓ Encapsulation of a Pharmaceutical load potential for diffusion, pH driven, thermally driven or material degradation drug delivery.
Load Versatility
✓ Accommodates varying particle sizing for multifunctional actions, layering and / or concentration gradients.
Media Retention
✓ Securely holds active components within the permeable (or a sided non-permeable) nonwoven fabrics.
Controlled Release
✓ Controllable gradients for disbursement via the fabric porosity, and further by particle size erosion rates.
Separation
✓ Option to distinctly layer fabrics from a point of inception to an activity pathway for the chosen application.
Filtration
✓ Specific powder mediums such as Zeolites (with tunable molecular blocking) can make for targeted filtration devices in gas or fluids.
Selective Capture
✓ Ion exchange powders or other fabric carried targeting molecules can hold onto passing contaminants.
Design Versatility
✓ Adaptable for diverse clinical needs, serving as a component piece or a standalone medical device.
Diagnostic Sensors
✓ Ability to accommodate off-the-shelf microsensors and simple tell-tale indicators for signaling environmental changes in use, such as; temperature / pH levels / protein concentration / oxygen levels / bacterial concentration in-situ.
Electrical Field Generation
✓ Embedded Electrical Field Generation An ability to incorporate thin metallic meshes to generate Electrical Stimulation (ES) for wound healing advancement / Potential for Microcurrent pain control also.
Fabric Matrix
✓ Options to select fabric permeability to suit each use case from highly breathable nonwovens to gas barrier films.
Incorporations
✓ Any fibers and any non-metallic mesh materials can be laminated into final products to modify the products mechanical properties or add ergonomic qualities.
NPWT
✓ Negative Pressure Wound Dressing able and may also be deformable for contour following in patient application.
A PRODUCT ENHANCEMENT FOR CURRENT APPLICATIONS - A NEW TECHNOLOGY
Wound and skin care
Ostomy, Continence and Feminine Hygiene
Negative pressure wound therapy
Diagnostics
Patient monitoring
Surgical
Medical wearables
Infection Control
Patent Protection & Licensing Process
Medical Fabrics Limited has filed this process patent and is using the fast-track prosecution service.
Medical Fabrics Limited has a straightforward process for accelerating party agreements:
1
1. Non-Disclosure Agreement
2
2. Exploratory face-to-face meeting
to understand your specific challenges or opportunities
3
3. Structured technology briefing
covering technical foundations, IP overview etc.
4
4. Term Sheet / Heads of Terms
for acquisition or development, outlining key terms:
  • Scope of licence (exclusive / non-exclusive, territory, field of use etc.)
  • Financials (upfront fee, milestones, royalties)
  • Duration & termination clauses
  • Rights to improvements
5
5. Legal Review
to analyse and align both parties' expectations
6
6. Draft Licence Agreement
to include key clauses: • Licence grant (scope, exclusivity) • Royalty and payment structure • Performance obligations (e.g. commercialisation timelines, reporting) • Confidentiality, indemnities, & dispute resolution
7
7. Execution of Licence Agreement
in which both parties finalise and sign the final agreement and begin transition to implmentation
8
8. Implementation & Commercialisation Planning
for operational readiness to include technology transfer, manufacturing setup, regulatory pathway (if applicable) etc.
Contact Our Team
Andrew Patchett
Co-Founder & Inventor
Inventor
+44 7307 199912
George Fellowes
Co-Founder & COO
Commercial
+44 7500 546605
James Saunders
Co-Founder CCO
Medical Devices
+44 7881 365050
MEDICAL FABRICS LIMITED